Now Available: Final Rule for FDAAA 801 and NIH Policy on Clinical Trial Reporting
2 studies found for:    20039425 [PUBMED-IDS]
Show Display Options
Rank Status Study
1 Completed A Study to Assess the Effect of Tocilizumab + Methotrexate on Signs and Symptoms in Patients With Moderate to Severe Active Rheumatoid Arthritis
Condition: Rheumatoid Arthritis
Interventions: Drug: tocilizumab [RoActemra/Actemra];   Drug: Placebo;   Drug: Methotrexate
2 Recruiting Filling Bone Erosions: a Longitudinal Multicentric HR-pQCT Study of Subcutaneous Tocilizumab in Rheumatoid Arthritis
Condition: Rheumatoid Arthritis
Intervention: Drug: subcutaneous tocilizumab

Study has passed its completion date and status has not been verified in more than two years.